- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade (Bortezomib)
Total 958 results
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
NCIC Clinical Trials GroupCompleted
-
University Hospital, Clermont-FerrandLaboratoires TakedaUnknownMultiple Myeloma | Adult | Bortezomib RegimenFrance
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Nantes University HospitalCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
University of RochesterCompletedMyelodysplastic SyndromesUnited States
-
Janssen Korea, Ltd., KoreaCompletedMultiple Myeloma
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIslet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Janssen Pharmaceutical K.K.CompletedMultiple Myeloma | Relapse | Refractory
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Chinese SLE Treatment And Research GroupRecruiting
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Indiana UniversityCompleted
-
National Cancer Institute (NCI)TerminatedGastrointestinal Cancer | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder... and other conditionsUnited States
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Janssen Korea, Ltd., KoreaCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
University of WuerzburgUnknownMultiple MyelomaAustria, Germany, Italy
-
National Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung CancerUnited States
-
Janssen-Cilag B.V.CompletedMultiple Myeloma | Hematological NeoplasmsNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Giselle ShollerBeat NB Cancer Foundation; Because of Ezra; K C Pharmaceuticals Inc.CompletedNeuroblastoma RecurrentUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Vejle HospitalOdense University HospitalCompletedMultiple MyelomaDenmark
-
Zhongnan HospitalRecruitingAcute Myeloid Leukemia | BortezomibChina
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Recurrent/Refractory Childhood Hodgkin Lymphoma | Stage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage I Adult Hodgkin Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage II Adult Hodgkin Lymphoma and other conditionsUnited States
-
Duke UniversityMillennium Pharmaceuticals, Inc.; Duke Cancer InstituteTerminated
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.Completed
-
Janssen Korea, Ltd., KoreaCompletedMultiple Myeloma
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
International Extranodal Lymphoma Study Group (IELSG)CompletedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Mahidol UniversityMinistry of Health, ThailandUnknown